Trospium Chloride in combination therapy of female genital prolapses and overactive bladder syndrome
Abstract
Based upon 28 follow-ups (women aged 55 to 82 years), the authors have researched into the efficiency of the trospium chloride used to treat overactive bladder syndrome followed by the surgical correction of genital prolapse. The results of urodynamic surveillance confirm this drug to be more efficient in cases of the detrusor hyperactivity. In cases of the overactive bladder syndrome with no detrusor hyperactivity the efficacy of the trospium chloride appears to be less obvious. The authors point to low occurrence and intensity of drug side effects. This allows to conclude that applying the trospium chloride is allowed from the patients’ safety standpoint to treat patients with the overactive bladder syndrome remained after surgical correction of genital prolapses.
About the Authors
M. E. Shkolnikov
Russian State Medical University named after N.I. Pirogov
Russian Federation
Russian Federation
E. B. Mazo
Russian State Medical University named after N.I. Pirogov
Russian Federation
Russian Federation
G. G. Krivoborodov
Russian State Medical University named after N.I. Pirogov
Russian Federation
Russian Federation
Yu. E. Dobrokhotova
Russian State Medical University named after N.I. Pirogov
Russian Federation
Russian Federation
M. M. Kaifajan
Russian State Medical University named after N.I. Pirogov
Russian Federation
Russian Federation
L. V. Fandeeva
Russian State Medical University named after N.I. Pirogov
Russian Federation
Russian Federation
R. F. Nurullin
Russian State Medical University named after N.I. Pirogov
Russian Federation
Russian Federation
M. S. Zhdanova
Russian State Medical University named after N.I. Pirogov
Russian Federation
Russian Federation
References
1. Мазо Е.Б., Кривобородов Г.Г. Гиперактивный мочевой пузырь. М.: Вече, 2003. 160 с.
2. Пушкарь Д.Ю. Гиперактивный мочевой пузырь у женщин. М.: МЕДпресс-информ, 2003. 160 с.
3. Смольнова Т.Ю., Буянова С.Н., Савельев С.В., Петрова В.Д. Дисплазия соединительной ткани как одна из возможных причин недержания мочи у женщин с пролапсом гениталий // Урология. 2001. № 2. С. 25-30.
4. Abrams P., Cardozo L., Fall M. et al. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society // Neurourol. Urodyn. 2002. Vol. 21. P. 167-178.
5. Fulford S.C., Flynn R., Barrington J. et al. An assessment of the surgical outcome and urodynamic effects of the pubovaginal sling for stress incontinence and the associated urge syndrome // J. Urol. 1999. Vol. 162, No. 1. P. 135-137.
6. Milsom I., Abrams P., Cardozo L. et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study // BJU Int. 2001. Vol. 87. P. 760-766.
7. Singh-Franco D., Machado С., Tuteja S., Zapantis A. Trospium Chloride for the treatment of overactive bladder with urge incontinence // Clinical Therapeutics. 2005. Vol. 27, No. 5. P. 511-530.
8. Staskin D.R., Harnett M.D. Effect of Trospium Chloride on Somnolence and Sleepiness in Patients with Overactive Bladder // Current Urology Reports. 2004. Vol. 5. P. 423-426.
9. Stewart W.F., Corey R., Herzog A.R. et al. Prevalence of overactive bladder in women: results from the NOBLE program // Int. Urogynecol. J. Pelvic Floor Dysfunct. 2001. Vol. 12. P. 66.
Review
For citations:
Shkolnikov M.E., Mazo E.B., Krivoborodov G.G., Dobrokhotova Yu.E., Kaifajan M.M., Fandeeva L.V., Nurullin R.F., Zhdanova M.S. Trospium Chloride in combination therapy of female genital prolapses and overactive bladder syndrome. Pacific Medical Journal. 2011;(1):26-28. (In Russ.)
Views:
240
Email this article 